- Home
- FRGT vs SONN Comparison
FRGT vs SONN Comparison
Compare FRGT & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGT
- SONN
- Stock Information
- Founded
- FRGT 2015
- SONN N/A
- Country
- FRGT United States
- SONN United States
- Employees
- FRGT N/A
- SONN N/A
- Industry
- FRGT Professional Services
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- FRGT Consumer Discretionary
- SONN Health Care
- Exchange
- FRGT Nasdaq
- SONN Nasdaq
- Market Cap
- FRGT 2.9M
- SONN 2.5M
- IPO Year
- FRGT N/A
- SONN N/A
- Fundamental
- Price
- FRGT $1.36
- SONN $1.54
- Analyst Decision
- FRGT
- SONN Strong Buy
- Analyst Count
- FRGT 0
- SONN 2
- Target Price
- FRGT N/A
- SONN $38.00
- AVG Volume (30 Days)
- FRGT 204.8K
- SONN 267.1K
- Earning Date
- FRGT 01-28-2025
- SONN 02-12-2025
- Dividend Yield
- FRGT N/A
- SONN N/A
- EPS Growth
- FRGT N/A
- SONN N/A
- EPS
- FRGT N/A
- SONN N/A
- Revenue
- FRGT $17,567,033.00
- SONN $18,626.00
- Revenue This Year
- FRGT $144.53
- SONN N/A
- Revenue Next Year
- FRGT $55.01
- SONN N/A
- P/E Ratio
- FRGT N/A
- SONN N/A
- Revenue Growth
- FRGT N/A
- SONN N/A
- 52 Week Low
- FRGT $1.25
- SONN $1.41
- 52 Week High
- FRGT $80.75
- SONN $18.72
- Technical
- Relative Strength Index (RSI)
- FRGT 38.55
- SONN 36.95
- Support Level
- FRGT $1.25
- SONN $1.46
- Resistance Level
- FRGT $1.47
- SONN $2.52
- Average True Range (ATR)
- FRGT 0.20
- SONN 0.18
- MACD
- FRGT -0.07
- SONN 0.06
- Stochastic Oscillator
- FRGT 10.09
- SONN 9.26
About FRGT Freight Technologies Inc.
Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.